Please login to the form below

Not currently logged in
Email:
Password:

David Haslam

This page shows the latest David Haslam news and features for those working in and with pharma, biotech and healthcare.

NHS England proposes handing CDF remit to NICE

NHS England proposes handing CDF remit to NICE

In fact, NICE argued the same in a parliamentary hearing in September last year after its chairman Professor David Haslam said that NHS England should be using its processes to assess

Latest news

  • WHO: Medicine costs ‘too high’ for European governments WHO: Medicine costs ‘too high’ for European governments

    This echoes the belief of Professor David Haslam, chair of England's health technology assessor NICE, who last year said pharma had to “ show its working” on how it came to

  • NICE wants greater access to clinical data NICE wants greater access to clinical data

    The announcement comes a week after NICE's chair Prof David Haslam (pictured right) told a House of Commons health select committee that pharma companies had a “ moral imperative” to publish ... Prof Haslam's colleague Prof Carole Longson, who is

  • Public advises NICE on value of care Public advises NICE on value of care

    Healthcare priorities included justice and respect. NICE chairman Professor David Haslam welcomed the draft report, adding that its conclusions will inform the update of the NICE societal value judgements document.

  • UK NHS needs to rethink long-term care UK NHS needs to rethink long-term care

    According to the Committee, these multimorbidities are not adequately recognised in a system set up to address single diseases – a thought backed up by David Haslam, chair of NICE.

  • Fox Communications leads comms for UK obesity week Fox Communications leads comms for UK obesity week

    We have been delighted with the materials created by Fox for what is a very important campaign,” said National Obesity Forum chairman Professor David Haslam. “

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • The death of the cancer drugs fund? The death of the cancer drugs fund?

    In fact, NICE argued the same in a parliamentary hearing in September last year after its chairman Professor David Haslam said that NHS England should be using its processes to assess

  • Interview: David Haslam, NICE Interview: David Haslam, NICE

    Interview: David Haslam, NICE. The new chair of the UK’ s NICE discusses navigating the stormy waters of health service reforms, collaborating with pharma and the introduction of VBP. ... His replacement, Professor David Haslam, is more than capable

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • David Haslam takes over as NICE chair David Haslam takes over as NICE chair

    David Haslam takes over as NICE chair. Replaces Sir Michael Rawlins as body gains new social care responsibilities. ... Professor David Haslam has taken over as chair of NICE on the same day it changed its name from the National Institute for Health and

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics